Rajagukguk RM. USE OF SODIUM-GLUCOSE TRANSPORT PROTEIN 2 (SGLT2) INHIBITORS IN DIABETIC KIDNEY DISEASE (DKD). JARMHS. 2023;9(4):46-52. doi:10.53555/nnmhs.v9i4.1653